One-year Survival Rate of Pancreatic Cancer and the Mortality Affecting Factors

Background:  Pancreatic cancer is the fourth leading cause of death associated with malignancy in the United States, and is thought to be the second leading cause of death in 2030 in the United Kingdom. In Asia, pancreatic cancer is the most fatal cancer with the lowest survival of all malignancies,...

Full description

Bibliographic Details
Main Authors: Alexander Michael Joseph Saudale, Marcellus Simadibrata, Rino Alvani Gani, Cleopas Martin Rumende
Format: Article
Language:English
Published: Interna Publishing 2020-09-01
Series:The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Subjects:
Online Access:https://www.ina-jghe.com/index.php/jghe/article/view/738
_version_ 1797810511617720320
author Alexander Michael Joseph Saudale
Marcellus Simadibrata
Rino Alvani Gani
Cleopas Martin Rumende
author_facet Alexander Michael Joseph Saudale
Marcellus Simadibrata
Rino Alvani Gani
Cleopas Martin Rumende
author_sort Alexander Michael Joseph Saudale
collection DOAJ
description Background:  Pancreatic cancer is the fourth leading cause of death associated with malignancy in the United States, and is thought to be the second leading cause of death in 2030 in the United Kingdom. In Asia, pancreatic cancer is the most fatal cancer with the lowest survival of all malignancies, 25-30% survival five years after surgery. Indonesia has no data on the survival of pancreatic cancer and the factors that affect it. The aim of this study is knowing the 1-year survival of pancreatic cancer and its influencing factors in Cipto Mangunkusumo Hospital, Jakarta. Method: A retrospective cohort study was performed using data from the medical records of pancreatic cancer patients dr. Cipto Mangunkusumo Hospital between January 2012 - December 2016. Factors age, sex, metastasis, stage, comorbid and treatment were analyzed bivariate and multivariate using Cox Proportional Hazards Regression to obtain Hazard Ratio (HR) for each prognostic factor. The cumulative survival of 1 year after diagnosis is expressed by the Kaplan-Meier curve. Results: Of 83 subjects the proportion of males was 62.7%, age ≥ 50 years 68.7%, with age range 33-79 years, and 55 years on average. In bivariate analysis, there was a statistically significant relationship of survival with comorbid variables (HR = 2,116, 95% 953 1,335-3,513, p 0,002), metastasis (HR = 3,802, 95% CI: 1,995-7,249, p 0.001), palliative treatment (HR = 2,108 , 95% CI: 1,077-4,125, p = 0,029) and group without treatment (HR = 2,924, 95% CI: 1,496-5,716, p = 0,002). Multivariate analysis showed that metastasis provided the greatest risk of death with HR = 4.306 (95% CI: 2.125-8.724, p 0.001). Palliative group HR was 2.510 (95% CI: 1,245-5,061 p = 0.010) while the group without treatment gave HR 2,535 (95% CI: 1,277-5,032 p = 0,008). The 1-year survival rate is 14%, with a median survival of 6 months. Conclusion: The overall survival of one year of pancreatic cancer patients was 14%, with a median survival of 6 months. The presence of metastasis and not the curative therapy of Whipple surgery in patients with pancreatic cancer in dr. Cipto Mangunkusumo Hospital is the main factor that negatively affect the survival of 1 year
first_indexed 2024-03-13T07:10:01Z
format Article
id doaj.art-acd0c57f4eef405a8efaed868a67841c
institution Directory Open Access Journal
issn 1411-4801
2302-8181
language English
last_indexed 2024-03-13T07:10:01Z
publishDate 2020-09-01
publisher Interna Publishing
record_format Article
series The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
spelling doaj.art-acd0c57f4eef405a8efaed868a67841c2023-06-06T04:42:02ZengInterna PublishingThe Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy1411-48012302-81812020-09-0121210811310.24871/2122020108-113704One-year Survival Rate of Pancreatic Cancer and the Mortality Affecting FactorsAlexander Michael Joseph Saudale0Marcellus Simadibrata1Rino Alvani Gani2Cleopas Martin Rumende3Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/ Dr. Cipto Mangunkusumo General National Hospital, JakartaDivision of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo General National Hospital, JakartaDivision of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo General National Hospital, JakartaDivision of Respirology and Critical Care, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr Cipto Mangunkusumo General National Hospital, JakartaBackground:  Pancreatic cancer is the fourth leading cause of death associated with malignancy in the United States, and is thought to be the second leading cause of death in 2030 in the United Kingdom. In Asia, pancreatic cancer is the most fatal cancer with the lowest survival of all malignancies, 25-30% survival five years after surgery. Indonesia has no data on the survival of pancreatic cancer and the factors that affect it. The aim of this study is knowing the 1-year survival of pancreatic cancer and its influencing factors in Cipto Mangunkusumo Hospital, Jakarta. Method: A retrospective cohort study was performed using data from the medical records of pancreatic cancer patients dr. Cipto Mangunkusumo Hospital between January 2012 - December 2016. Factors age, sex, metastasis, stage, comorbid and treatment were analyzed bivariate and multivariate using Cox Proportional Hazards Regression to obtain Hazard Ratio (HR) for each prognostic factor. The cumulative survival of 1 year after diagnosis is expressed by the Kaplan-Meier curve. Results: Of 83 subjects the proportion of males was 62.7%, age ≥ 50 years 68.7%, with age range 33-79 years, and 55 years on average. In bivariate analysis, there was a statistically significant relationship of survival with comorbid variables (HR = 2,116, 95% 953 1,335-3,513, p 0,002), metastasis (HR = 3,802, 95% CI: 1,995-7,249, p 0.001), palliative treatment (HR = 2,108 , 95% CI: 1,077-4,125, p = 0,029) and group without treatment (HR = 2,924, 95% CI: 1,496-5,716, p = 0,002). Multivariate analysis showed that metastasis provided the greatest risk of death with HR = 4.306 (95% CI: 2.125-8.724, p 0.001). Palliative group HR was 2.510 (95% CI: 1,245-5,061 p = 0.010) while the group without treatment gave HR 2,535 (95% CI: 1,277-5,032 p = 0,008). The 1-year survival rate is 14%, with a median survival of 6 months. Conclusion: The overall survival of one year of pancreatic cancer patients was 14%, with a median survival of 6 months. The presence of metastasis and not the curative therapy of Whipple surgery in patients with pancreatic cancer in dr. Cipto Mangunkusumo Hospital is the main factor that negatively affect the survival of 1 yearhttps://www.ina-jghe.com/index.php/jghe/article/view/738pancreatic cancersurvivalinfluencing factors
spellingShingle Alexander Michael Joseph Saudale
Marcellus Simadibrata
Rino Alvani Gani
Cleopas Martin Rumende
One-year Survival Rate of Pancreatic Cancer and the Mortality Affecting Factors
The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
pancreatic cancer
survival
influencing factors
title One-year Survival Rate of Pancreatic Cancer and the Mortality Affecting Factors
title_full One-year Survival Rate of Pancreatic Cancer and the Mortality Affecting Factors
title_fullStr One-year Survival Rate of Pancreatic Cancer and the Mortality Affecting Factors
title_full_unstemmed One-year Survival Rate of Pancreatic Cancer and the Mortality Affecting Factors
title_short One-year Survival Rate of Pancreatic Cancer and the Mortality Affecting Factors
title_sort one year survival rate of pancreatic cancer and the mortality affecting factors
topic pancreatic cancer
survival
influencing factors
url https://www.ina-jghe.com/index.php/jghe/article/view/738
work_keys_str_mv AT alexandermichaeljosephsaudale oneyearsurvivalrateofpancreaticcancerandthemortalityaffectingfactors
AT marcellussimadibrata oneyearsurvivalrateofpancreaticcancerandthemortalityaffectingfactors
AT rinoalvanigani oneyearsurvivalrateofpancreaticcancerandthemortalityaffectingfactors
AT cleopasmartinrumende oneyearsurvivalrateofpancreaticcancerandthemortalityaffectingfactors